KOOS-12 Score in Knee Osteoarthritis Patients
Data Collection
Collected from today forward - ProspectiveArthritis+3
+ Joint Diseases
+ Musculoskeletal Diseases
Cohort
Tracking disease incidence in order to identify risk factors and understand disease progression over time.Summary
Study start date: March 20, 2025
Actual date on which the first participant was enrolled.Osteoarthritis (OA) is a common condition that affects the joints, causing significant pain and disability. As the population ages and unhealthy lifestyle habits become more common, the prevalence and impact of OA continue to grow. This study focuses on knee OA and aims to understand the effectiveness of various non-surgical treatments. The main goal is to determine how responsive patients are to these treatments and identify the minimal clinically important difference in the Knee Injury and Osteoarthritis Outcome Score-12 (KOOS-12), a measure used to assess the condition of patients with knee OA. Participants in this study will be asked to complete a questionnaire known as the Global Rating of Change (GRC). This questionnaire will ask them to compare their current condition to their condition at the start of the study, using a scale ranging from -7 (a very great deal worse) to 7 (a very great deal better). Based on their responses, participants will be categorized into either a 'change' group or a 'no change' group. Additionally, the KOOS-12 score will be used to evaluate pain, function, and quality of life. Each item in this score ranges from 0 to 4, with a mean score of 100. A score of 0 indicates severe functional difficulties, while a score of 100 indicates normal function.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.60 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Cohort
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 50 to 65 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Study Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Chaudary Muhammad Akram Teaching Hospital, Azra Naheed Medical College, Superior University
Lahore, PakistanOpen Chaudary Muhammad Akram Teaching Hospital, Azra Naheed Medical College, Superior University in Google Maps